The how and why of Acute HIV Infection 1. How do we best diagnosis patients with acute HIV?

Similar documents
Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012

Diagnosing HIV Infection AMNERIS E. LUQUE, M.D. PROFESSOR OF MEDICINE/INFECTIOUS DISEASES MEDICAL DIRECTOR, PARKLAND HIV SERVICES

Lisa K. Fitzpatrick, MD, MPH Associate Professor of Medicine Howard University School of Medicine

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

General Medical Concerns

Hepatitis B (Part 1 - intro)

HIV Basics: Pathogenesis

Clinical Manifestations of HIV

Infectious Mononucleosis The Virus Pathophysiology: Age: History: Fever. Lymphadenopathy

Primary Human Immunodeficiency Virus Infection Presenting as Elevated Aminotransferases

HIV Basics: Clinical Tests and Guidelines

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Herpes virus co-factors in HIV infection

INTEGRATING HIV INTO PRIMARY CARE

Objectives. HIV in the Trenches HIV Update for the Primary Care Provider, An Overview The HIV Continuum of Care.

The Dubbo Infection Outcomes Study

EBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Other Diagnostic Tests

Some medical conditions require exclusion from school or child care to prevent the spread of infectious diseases among staff and children.

Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

VAERS Cases of Pancreatitis and Pancreatitis Acute

Cleaning for Additional Precautions Table symptom based

Hepatitis and Herpes Viruses. These two virus groups are very diverse, but cause much human morbidity and mortality

0% 0% 0% Parasite. 2. RNA-virus. RNA-virus

Students. Exhibit - Reporting and Exclusion Requirements for Common Communicable Disease. Reporting Mandated to Local Health Authority

How is it transferred?

A case of acute liver failure in HIV/HBV co-infection

Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan

Immunodeficiencies HIV/AIDS

NASRONUDIN 4/17/2013. DENVs of each type are grouped into several genotypes.

BLOCK 12 Viruses of the ENT

Infectious diseases Dr n. med. Agnieszka Topczewska-Cabanek

The Kinder Garden. Aim. Legislative Requirements. Who is affected by this policy? Implementation. Infectious Diseases Policy

Management of Severe Primary HIV Infection

Diseases of Absence. Disclosures

Mohammed El-Khateeb MSVL-4 Nov 26 th 2013

Exclusion Periods for Infectious Diseases

Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST

Blood Borne Pathogens. November 2010

Joanne Stekler, MD, MPH Assistant Professor of Medicine Deputy Director, Public Health Seattle & King County HIV/STD Program

Post-Exposure Prophylaxis Review for International Visitors

A rash case Infection control management of measles

Hepatitis A Virus: Old Things Made New

Memo No: Date: 25-Nov NEW Serology and Virology Testing

Class 10. DNA viruses. I. Seminar: General properties, pathogenesis and clinial features of DNA viruses from Herpesviridae family

PrEP in the Real World: Clinical Case Studies

West Nile Virus. Syndrome. (Family: Flaviviridae) Severe Manifestations (Typically >50 years of age) NEUROLOGICAL (Meningoencephalitis >Meningitis)

Chapters 21-26: Selected Viral Pathogens

Morning Report. Thursday, April 9, 2015 Danielle Eggie

VZV, EBV, and HHV-6-8

Multiple Choice Questions - Paper 1

HIV/AIDS Definition: CDC Classification of HIV Infection Stage 1: Stage 2: Stage 3: Risk Factors

Human Herpesviruses. Medical Virology, 27 Nov 2015.

Pretreatment Evaluation

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

Opportunistic infections in the era of cart, still a problem in resource-limited settings

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

GOALS AND OBJECTIVES INFECTIOUS DISEASE

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

INFECTIOUS DISEASES PROCEDURE

Pet Pigs and Pyrexia

Objectives. Dengue, Chikungunya and Zika Virus Infection: Answers to Common Questions. Case 1. Dengue Introduction 10/15/2018

Wherever possible it is recommended that a child receive their vaccination on a day when they will not be attending the centre..

Current Infectious Disease Screening for the Live Organ Donor

Quick Study: Sexually Transmitted Infections

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

Viruses. CLS 212: Medical Microbiology Miss Zeina Alkudmani

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018

INFECTIOUS DISEASES POLICY

Hepatitis A Hepatitis D Hepatitis E HSV CMV EBV

Diagnosis of Acute HCV Infection

Human Herpesviruses. VZV, EBV, and HHV-6-8. The rash of VZV is vesicular. MID 34

Mathematical-Statistical Modeling to Inform the Design of HIV Treatment Strategies and Clinical Trials

Viral Diseases. T Bamdad, PhD, Tarbiat Modares University

What Does HIV Do to You?

Increase in Locally-Acquired Cyclosporiasis Cases in Ontario

CASE STUDY. Adverse Events in treatment chronic hepatitis C patients with PegInterferon and Ribavirin What would your management decision be?

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers

Repetitorium of selected human viruses HIV

Virology Serology Diagnostics Infection Training Dr Alison Watt

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

CASE-BASED SMALL GROUP DISCUSSION

Epstein-Barr Virus 1

Viral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH

الحترمونا من خري الدعاء

Disease Transmission( Spread) Symptoms Infectious Period/ Exclusion. Should see physician as antibiotic treatment may be required

RESPIRATORY TRACT INFECTIONS. CLS 212: Medical Microbiology Zeina Alkudmani

CASE-BASED SMALL GROUP DISCUSSION MHD II

Epstein-Barr Virus in a Toddler. Elaine Bullock, MD Pediatrics LSU Health Shreveport Louisiana Chapter AAP Pediatric Potpourri on the Bayou

BRAINZ POLICY AND PROCEDURE ON COMMUNICABLE DISEASES

A summary of guidance related to viral rash in pregnancy

A challenging neurological complication in a young HIV-infected woman

Preventing Sexual Transmitted Diseases

Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) virus infection in China

Transcription:

Acute HIV infection Eric Rosenberg, MD Associate Professor of Pathology Director, Clinical Microbiology Laboratory Massachusetts General Hospital Harvard Medical School

The how and why of Acute HIV Infection 1. How do we best diagnosis patients with acute HIV? Clinical presentation Differential diagnosis Laboratory markers 2. Why should we diagnosis patients with acute HIV? Transmission Treatment Treatment interuption

Diagnosis

How often do we see Acute HIV? 0.3% consecutive, unselected ED visits (Clark, JID 1994) 1% urgent care clinic patients with any symptom of a viral illness at BMC (Pincus, CID 2003) 1% of MGH patients tested for EBV mononucleosis with a negative heterophile (Rosenberg, NEJM 1999)

How do patients with acute HIV present?

Commonly reported signs and symptoms fever >80-90 % fatigue >70-90 % rash 50-60 % myalgia/arthralgia 50-70 % pharyngitis 50-70 % Lymphadenopathy > 50% nightsweats 50 % n/v/d 30-60 %

Less commonly reported signs and symptoms Leukopenia/thrombocytopenia 40-45 % weight loss 25 % aseptic meningitis 24 % anorexia 21 % increased LFT s 20 % oral ulcers 10-20 % genital ulcers 5-15 % cough/uri diagnosis very unlikely

Acute HIV Differential diagnosis EBV (1% of negative mono spots = ARS) CMV Streptococcal infection/pharyngitis HSV Influenza Acute Hepatitis A, B and C Toxoplasmosis (acute) Rubella/Measles Endocarditis

Which of the following patient s has acute HIV?

Patient 1: A 35 year old man with fever, rash, fatigue and nausea 35 year old man (IVDU) presents to the emergency room with: Fever to 102.2 Rash Fatigue Nausea, anorexia, diarrhea WBC 7, HCT 42, PLT 290, Ast 478, Alt 509, Tb 2.3 Does this patient have acute HIV?

What is the diagnosis? 1. Acute HIV infection 2. Bacterial endocarditis 3. Acute Epstein-Barr virus infection 4. Acute Cytomegalovirus infection 5. Acute Hepatitis C infection

Patient 1 Rapid strept test negative HIV ELISA negative HIV RNA < 50 copies /ml plasma EBV heterophile negative CMV IgM negative, IgG positive HCV Ab negative HCV RNA > 700,000 copies/ml Dx= Acute Hepatitis C virus infection

Patient 2: A 20 year old man with fever, sore throat, lymphadenopathy and weight loss 20 year old MSM presents to MGH medical walk-in clinic complaining of: Fever X 2 weeks (103.2 on exam) Sore throat, Lymphadenopathy Fatigue, myalgia, arthralgia Nausea, vomiting, diarrhea and abdomen cramps. 8 lb weight loss WBC 1.5, 12% atypical lymphocytes, HCT 40, Plt 127, ALT 240, AST 280 Does this patient have acute HIV?

What is the diagnosis? 1. Acute HIV infection 2. Bacterial endocarditis 3. Acute Epstein-Barr virus infection 4. Acute Cytomegalovirus infection

Patient 2 HIV ELISA negative HIV RNA < 50 copies /ml plasma EBV heterophile negative CMV IgM 5 units, IgG Negative CMV DNA Positive HCV Ab negative HCV RNA undetectable Dx= Acute CMV infection

Patient 3: 47 year old male with fever, headache and photophobia Present to MGH ED with an 8 day history of : Fever to 102.5 Headache Photophobia Myalgias and arthralgias Nausea and vomiting 3 rd visit to health care system

47 year old male Exam: Fever Oral ulcer Cervical lymphadenopathy Rash (started on torso spread to limbs and scalp) Data: WBC 7.6 (ALC 0.75) CSF 11 WBC s (70% lymphocytes)

Data: WBC 7.6 (ALC 0.75) 47 year old male EBV monospot negative CMV IgM negative, CMV IgG + CSF 11 WBC s (70% lymphocytes) HIV 4 th generation screening test (Ag/Ab) Positive HIV-1/2 differentiation assay Negative HIV RNA: 47,000,000 copies/ml

Diagnosis Acute HIV Infection

Diagnosis

Laboratory Markers and Terminology Branson, JAIDS 2010

Making the diagnosis of Acute HIV Must have a very high level of suspicion Risk factors Physical exam critical HIV ELISA 4 th generation (Ab/Ag) closes window ~7d HIV-1/HIV-2 Differentiation assay HIV RNA

Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations Branson et al, CDC/APHL

Why is it important to make the diagnosis of Acute HIV infection?

Transmission Making the diagnosis of acute HIV infection help may stop unknowing transmission of HIV

Transmission of HIV is greatest during acute and early HIV infection 12 times more likely to transmit Wawer et al, JID 2005:191 Time after seroconversion

Treatment Should individuals with Acute HIV-1 infection be treated with antiretroviral therapy?

Advantages Preservation of HIV-specific cellular immune responses Opportunity for structured treatment interruption Lowering of HIV-1 set point Limitation of viral evolution and diversity Decreased transmission Mitigation of acute retroviral symptoms Disadvantages Toxicities and unknown long-term risks Short- and long-term clinical benefits are not well-defined Resistance acquisition Limitation of future antiretroviral therapy options Quality of life impact Cost Kassutto et al, Clinical Infectious Diseases 2006

SPARTAC trial Short Pulse Antiretroviral Therapy at Seroconversion 48 weeks course of therapy delayed disease progression although not much longer than the course of treatment NEJM, January 17, 2013

Primo-SHM Trial: No Treatment versus 24 or 60 weeks of Antiretroviral Treatment during Primary HIV infection Strongest evidence to date that early therapy may delay need for therapy in chronic infection Grijsen et al, PLOS Medicine, March 2012

Conclusions The early events in acute HIV infection may represent a unique window of opportunity for treatment It is not known whether treatment during acute infection is the right thing to do Making the diagnosis of Acute HIV infection is the correct thing to do Treatment followed by discontinuation of therapy may have a role in management of acute infection but optimal approach not known.